Practical approaches to limited resources

Vox Sanguinis, Supplement

Volumn 87, Issue 2, 2004, Pages

  Lin, Che Kit ^a  

^a Hong Kong Red Cross Blood T S ^*  (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; CONFERENCE PAPER; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; LABORATORY TEST; PRIORITY JOURNAL;

BLOOD BANKS; BLOOD DONORS; BLOOD TRANSFUSION; COMMUNICABLE DISEASE CONTROL; HEALTH SERVICES NEEDS AND DEMAND; HOSPITALS, TEACHING; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; QUALITY ASSURANCE, HEALTH CARE; SAFETY; TISSUE AND ORGAN PROCUREMENT;

EID: 4444328636     PISSN: 17416892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Gorham M. Scarce resources in an affluent society. Striving for zero risk? Vox Sang 2002; 83:133-136
2. Forbes JM, Anderson MD, Anderson GF, Bleecker GC, Rossi EC, Moss GS: Blood transfusion costs: a multi-centre study. Transfusion 1991; 31:318-323
3. Sullivan M, Umana W, Greer J: Comprehensive report on blood collection and transfusion in the United States in 1999. Bethesda: National Blood Data Resource, 2001
4. Williams A, Orton S: 'There's something about blood', a scientific perspective on blood donor qualification. In: Stramer S eds. Blood Safety In The New Millennium. Bethesda: Am Assoc Blood Banks, 2001; 1-32
5. Archer GT, Buring ML, Clark B et al: Prevalence of hepatitis C virus antibodies in Sydney blood donors. Med J Aust 1992; 157:225-227
6. Glynn SA, Kleinman SH, Schreiber GB et al.: Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991-96. Retrovirus Epidemiol Donor Study (REDS) JAMA 2000; 284:229-235
7. Kakaiya RM, Jacobs B, Pelletier M, Morse EE, Cable RG: Trends in hepatitis B surface antigen (HBsAg) prevalence in volunteer blood donors in Connecticut, 1973-83. Ann Clin Lab Sci 1986; 16:380-385
8. Kyriakis KP, Foudoulaki LE, Papoulia EI, Sofroniadou KE: Seroprevalence of hepatitis B surface antigen (HBsAg) among first-time and sporadic blood donors in Greece: 1991-96. Transfus Med 2000; 10:175-180
9. MacLennan S, Moore MC, Hewitt PE, Nicholas S, Barbara JA: A study of anti-hepatitis C positive blood donors: the first year of screening. Transfus Med 1994; 4:125-133
10. Murphy EL, Bryzman S, Williams AE et al.: Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996; 275:995-1000
11. Williams AE, Thomson RA, Schreiber GB, Watanabe K, Bethel J, Lo A, Kleinman SH, Hollingsworth CG, Nemo GJ: Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiol Donor Study JAMA 1997; 277:967-972
12. Dhingra N: Blood safety in the developing world and WHO initiatives. Vox Sang 2002; 83:173-177
13. Allain J-P, Owusu-Ofori S, Spare-Sem O: Pre-donation Screening of Blood Donors for Viral Markers: Providing Safer and Cheaper Blood, VIII European Congress of the International Society of Blood Transfusion, 2003 Plenaries and state of the art book, 141-144
14. Martinez MC: Management of scarce resources in blood services in developing countries. Vox Sang 2002; 83:137-140